PolyNovo (ASX:PNV) Insider David Williams Purchases 55,000 Shares of Stock

PolyNovo Limited (ASX:PNV) insider David Williams purchased 55,000 shares of the stock in a transaction on Friday, September 19th. The shares were purchased at an average cost of A$1.60 per share, for a total transaction of A$88,000.00.

David Williams also recently made the following trade(s):

• On Monday, September 15th, David Williams purchased 50,030 shares of PolyNovo stock. The shares were purchased at an average cost of A$1.50 per share, for a total transaction of A$75,045.00.
• On Friday, September 12th, David Williams purchased 61,335 shares of PolyNovo stock. The shares were purchased at an average cost of A$1.40 per share, for a total transaction of A$85,991.67.
• On Thursday, September 11th, David Williams acquired 31,000 shares of PolyNovo stock. The shares were bought at an average price of A$1.39 per share, for a total transaction of A$42,935.00.
• On Wednesday, September 10th, David Williams acquired 37,000 shares of PolyNovo stock. The shares were bought at an average price of A$1.41 per share, for a total transaction of A$51,985.00.

PolyNovo Price Performance

The stock has a market capitalization of $1.30 billion, a price-to-earnings ratio of 247.31, a price-to-earnings-growth ratio of 2.63 and a beta of 1.67. The company has a current ratio of 3.41, a quick ratio of 1.58 and a debt-to-equity ratio of 21.32.

About PolyNovo

PolyNovo Limited develops medical devices in the United States, Australia, New Zealand, the United Kingdom, Ireland, Singapore, and internationally. The company offers NovoSorb Biodegradable Temporising Matrix, which is used in a fully debrided clean surgical wound to physiologically close the wound.